Cargando…
Protection Against Breakthrough Delta/Omicron Variants in Vaccinated Patients with Myeloproliferative Neoplasms (MPN)
Ejemplares similares
-
Second Versus First Wave of COVID-19 in Patients with MPN
por: Barbui, Tiziano, et al.
Publicado: (2021) -
Breakthrough infections in MPN-COVID vaccinated patients
por: Barbui, Tiziano, et al.
Publicado: (2022) -
Second versus first wave of COVID-19 in patients with MPN
por: Barbui, Tiziano, et al.
Publicado: (2022) -
Long-term follow-up of recovered MPN patients with COVID-19
por: Barbui, Tiziano, et al.
Publicado: (2021) -
Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19
por: Barbui, Tiziano, et al.
Publicado: (2021)